First Page | Document Content | |
---|---|---|
Date: 2016-07-18 05:53:44Antifungals F2G Aspergillosis Mycosis Amphotericin B | PRESS RELEASE F2G Ltd announces the appointment of Ralf Schmid to the position of Chief Financial Officer MANCHESTER, UK – 11 JulyF2G Ltd, the UK-based antifungal drug discovery and development company, today aAdd to Reading ListSource URL: sunstone.euDownload Document from Source WebsiteFile Size: 156,89 KBShare Document on Facebook |